Get the Stockscreener App
0.798
5.05%
-0.0424
After Hours:
.80
0.002
+0.25%
Moleculin Biotech Inc Stock (MBRX) Forecast
The Moleculin Biotech Inc (MBRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.9783, representing a +273.22% increase from the current price of $0.798. The highest analyst price target is $4.8307, and the lowest is $1.1258.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MBRX Price Target
Average 4.6876
(+487.42% Upside)
Is Moleculin Biotech Inc (MBRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 18.02 | Buy |
| STOCH(9,6) | 6.152 | Buy |
| STOCHRSI(14) | 2.2817 | Buy |
| MACD(12,26) | -0.2553 | Sell |
| ADX(14) | 33.06 | Sell |
| William %R | -98.10 | Buy |
| CCI(14) | -181.09 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.3194
Sell
|
1.2288
Sell
|
| MA20 |
1.5397
Sell
|
1.4496
Sell
|
| MA50 |
1.9109
Sell
|
1.8064
Sell
|
| MA100 |
2.2268
Sell
|
2.2327
Sell
|
| MA200 |
2.9602
Sell
|
3.3501
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MBRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on MBRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 18.02 indicates that MBRX is oversold. This indicates that MBRX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 6.152 indicates that MBRX is oversold. This indicates that MBRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.2817 indicates that MBRX is oversold. This suggests that MBRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.06 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -181.09 indicates that MBRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MBRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Moleculin Biotech Inc financial reports and earnings history, Moleculin Biotech Inc (MBRX) stock could reach $2.5661 by 2030, $4.9462 by 2040 and $9.2319 by 2050. See the projected annual prices until 2050 of the Moleculin Biotech Inc stock below:
- Moleculin Biotech Inc (MBRX) is expected to reach an average price of $3.0616 in 2035, with a high prediction of $3.1371 and a low estimate of $3.0987. This indicates an $283.66% rise from the last recorded price of $0.798.
- Moleculin Biotech Inc (MBRX) stock is projected to chart a bullish course in 2040, with an average price target of $4.9968, representing an $526.16% surge from its current level. The forecast ranges from a conservative $4.8975 to a sky-high $4.9462.
- Our analysts predict Moleculin Biotech Inc (MBRX) to jump 774.69% by 2045, soaring from $6.8165 to an average price of $6.98, potentially reaching $6.90. While $6.8165 is the low estimate, the potential upside is significant.
- Moleculin Biotech Inc (MBRX) stock is expected to climb by 2050, reaching an average of $9.0967, a $1,040% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.2319 and $9.2623, respectively, highlighting the market's uncertainty.
Moleculin Biotech Inc Stock (MBRX) Year by Year Forecast
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2025
Moleculin Biotech Inc Stock (MBRX) is expected to reach an average price of $4.6876 in 2025, with a high prediction of $9.3611 and a low estimate of $0.0141. This indicates an +487.42% rise from the last recorded price of $0.798.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $1.5458 | $1.1258 | $4.8307 | +93.72% |
| April, 2025 | $1.195 | $0.0141 | $2.389 | +49.76% |
| May, 2025 | $4.3872 | $0.6791 | $9.3611 | +449.78% |
| June, 2025 | $3.9794 | $3.7333 | $4.8102 | +398.67% |
| July, 2025 | $3.5746 | $3.0374 | $4.8915 | +347.94% |
| August, 2025 | $2.7209 | $2.4599 | $3.8716 | +240.97% |
| September, 2025 | $4.0789 | $2.2698 | $6.8928 | +411.14% |
| October, 2025 | $2.2215 | $1.9341 | $4.2619 | +178.38% |
| November, 2025 | $2.5025 | $1.9371 | $3.0263 | +213.59% |
| December, 2025 | $1.7869 | $1.7215 | $2.9723 | +123.92% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2026
The predicted value for Moleculin Biotech Inc (MBRX) in 2026 is set at an average of $3.4727. Estimates vary from a peak of $6.4671 to a trough of $0.4783, indicating an +335.17% surge from the present price of $0.798.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.2976 | $1.5601 | $2.7506 | +187.92% |
| February, 2026 | $2.5462 | $2.1195 | $4.9797 | +219.07% |
| March, 2026 | $3.4979 | $2.3044 | $4.2179 | +338.34% |
| April, 2026 | $2.6231 | $2.0371 | $6.4671 | +228.71% |
| May, 2026 | $1.8353 | $0.8593 | $2.6612 | +129.99% |
| June, 2026 | $1.5075 | $1.3714 | $2.4814 | +88.90% |
| July, 2026 | $1.0327 | $0.8435 | $1.6905 | +29.41% |
| August, 2026 | $1.6048 | $1.0257 | $1.7348 | +101.10% |
| September, 2026 | $1.32 | $1.08 | $1.6779 | +65.42% |
| October, 2026 | $0.8622 | $0.7822 | $1.5031 | +8.04% |
| November, 2026 | $0.8643 | $0.4783 | $0.9452 | +8.31% |
| December, 2026 | $0.7995 | $0.5965 | $0.9874 | +0.19% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Moleculin Biotech Inc (MBRX) is $0.4255, with a high forecast of $0.8248 and a low forecast of $0.0261. This indicates an -46.68% decrease from the last price of $0.798.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.5417 | $0.4156 | $0.8248 | -32.12% |
| February, 2027 | $0.0239 | $0.0261 | $0.5647 | -97.01% |
| March, 2027 | $0.0209 | $0.1309 | $0.166 | -97.38% |
| April, 2027 | $0.4388 | $0.1529 | $0.3188 | -45.02% |
| May, 2027 | $0.6466 | $0.6352 | $0.6097 | -18.97% |
| June, 2027 | $0.8014 | $0.6736 | $0.7145 | +0.43% |
| July, 2027 | $0.3293 | $0.4493 | $0.7584 | -58.74% |
| August, 2027 | $0.2771 | $0.2932 | $0.2562 | -65.28% |
| September, 2027 | $0.5719 | $0.5441 | $0.6949 | -28.33% |
| October, 2027 | $0.5797 | $0.6445 | $0.5797 | -27.35% |
| November, 2027 | $0.3676 | $0.6336 | $0.5667 | -53.94% |
| December, 2027 | $0.4224 | $0.3615 | $0.3113 | -47.07% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2028
In 2028, Moleculin Biotech Inc (MBRX) is projected to reach an average price of $0.8431, with a high projection of $1.2868 and a low estimate of $0.3993. This indicates an +5.65% rise from the last price of $0.798.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6002 | $0.3993 | $0.4902 | -24.79% |
| February, 2028 | $0.9581 | $0.6872 | $0.8081 | +20.06% |
| March, 2028 | $1.0029 | $0.965 | $1.0161 | +25.67% |
| April, 2028 | $0.7007 | $0.8807 | $1.0248 | -12.19% |
| May, 2028 | $0.7655 | $0.6745 | $0.6455 | -4.07% |
| June, 2028 | $0.6833 | $0.7385 | $0.7424 | -14.37% |
| July, 2028 | $0.7794 | $0.7403 | $0.6642 | -2.33% |
| August, 2028 | $0.896 | $0.7351 | $0.689 | +12.28% |
| September, 2028 | $1.0038 | $0.9929 | $0.9638 | +25.79% |
| October, 2028 | $1.1117 | $1.0608 | $1.1168 | +39.32% |
| November, 2028 | $1.2872 | $1.3152 | $1.2581 | +61.31% |
| December, 2028 | $1.3055 | $1.3234 | $1.2868 | +63.59% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2029
The 2029 price forecast for Moleculin Biotech Inc Stock (MBRX) is $2.7775 on average, with a high prediction of $4.4895 and a low estimate of $1.0655. This represents an +248.06% increase from the previous price of $0.798.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2359 | $1.2291 | $1.2837 | +54.87% |
| February, 2029 | $1.2949 | $1.266 | $1.2579 | +62.27% |
| March, 2029 | $1.4478 | $1.2993 | $1.3948 | +81.42% |
| April, 2029 | $1.3826 | $1.4296 | $1.4117 | +73.26% |
| May, 2029 | $1.2774 | $1.3249 | $1.3136 | +60.08% |
| June, 2029 | $1.1952 | $1.2252 | $1.201 | +49.78% |
| July, 2029 | $0.9347 | $1.1731 | $1.1922 | +17.13% |
| August, 2029 | $1.2739 | $1.0655 | $1.2479 | +59.63% |
| September, 2029 | $1.2259 | $1.2858 | $1.255 | +53.62% |
| October, 2029 | $3.9542 | $1.1554 | $4.4895 | +395.51% |
| November, 2029 | $2.9116 | $2.5416 | $4.4873 | +264.87% |
| December, 2029 | $2.44 | $2.14 | $3.76 | +205.76% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2030
Moleculin Biotech Inc Stock (MBRX) is expected to reach an average price of $1.5207 in 2030, with a high forecast of $2.9565 and a low forecast of $0.085. This signifies an +90.57% surge from the last price of $0.798.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.6904 | $1.0782 | $2.5661 | +111.83% |
| February, 2030 | $2.4947 | $1.6365 | $2.9565 | +212.62% |
| March, 2030 | $1.199 | $1.019 | $2.7408 | +50.26% |
| April, 2030 | $1.6434 | $0.9051 | $2.0573 | +105.94% |
| May, 2030 | $1.5538 | $1.3494 | $2.6216 | +94.71% |
| June, 2030 | $1.6981 | $0.9598 | $1.8181 | +112.79% |
| July, 2030 | $1.3685 | $1.0624 | $1.8422 | +71.49% |
| August, 2030 | $1.0328 | $0.6728 | $1.5546 | +29.42% |
| September, 2030 | $0.6071 | $0.085 | $1.1589 | -23.92% |
| October, 2030 | $0.4125 | $0.1154 | $2.3415 | -48.31% |
| November, 2030 | $2.2901 | $0.4664 | $1.0481 | +186.99% |
| December, 2030 | $1.5038 | $1.6238 | $1.3238 | +88.45% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):